Azioni LogicBio Therapeutics, Inc.
Azioni
LOGC
US54142F1021
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 57 | 01/04/16 |
Marie Payton
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/19 |
Matthias Hebben
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/19 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 57 | 01/04/16 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,47% | 556 Mrd | |
-6,33% | 354 Mrd | |
+19,90% | 331 Mrd | |
+7,95% | 296 Mrd | |
+12,64% | 233 Mrd | |
+5,28% | 201 Mrd | |
-9,98% | 193 Mrd | |
-12,26% | 143 Mrd | |
-6,47% | 144 Mrd |